跳至主要内容
临床试验/NCT02663973
NCT02663973已完成不适用

Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III

Latin American Cooperative Oncology Group24 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3,000
试验地点
24
主要终点
Description of the epidemiology of breast cancer in the Brazilian population

研究概览

简要总结

The principal goal of this study is to describe the epidemiology of breast cancer in the Brazilian population

详细描述

The principal goal of this study is to describe the epidemiology of breast cancer in the Brazilian population. Other specific goals are:

  • To evaluate the demographic and socio-demographic profile, comorbidities and reproductive risks, anthropometric profile and family history.
  • Characterize the breast tumors immunophenotype through anatomopathological data, such as: tumor grade, estrogen receptor, progesterone receptor, HER2, Ki67.
  • Describe the screening tests, main symptoms and cancer stage in the moment of the diagnosis.
  • Describe the initial cancer treatment and locally advanced such as surgery, radiotherapy, chemotherapy and endocrine therapy.
  • Describe palliative treatment for recurrent or metastatic breast cancer: chemotherapy, radiotherapy, biphosphonate, and others.
  • Evaluate the clinical outcomes such as: local or diffuse relapse, period of time until progression to metastatic cancer, global lifespan and specific breast cancer lifespan.
  • Evaluate clinical complications of the metastatic disease, such as: brain metastasis, spinal cord compression, skeletal related events.
  • Analyze the demographical and socio-economical characteristics, clinical-pathological characteristics of the tumor, treatment, clinical outcomes, type of institution (private/public), and other factors that may impact clinical outcome.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Woman ≥ 18 years old
  • Invasive breast cancer stage I to IV proven by histology or cytology
  • Patients with new pathological diagnosis of invasive primary BC after the site activation date
  • Pathological diagnosis of invasive breast cancer during recruitment (6 months before center activation or until 3000 patients included)
  • New primary cancer on the same breast or contralateral breast.
  • Patient's medical chart is available and adequate for data collection
  • Patient properly signed the informed consent form

排除标准

  • 未提供

结局指标

主要结局

Description of the epidemiology of breast cancer in the Brazilian population

时间窗: Annually, during 5 years

次要结局

  • Characterization of the immunophenotypic markers of the tumor(Annually, during 5 years)
  • Initial treatment for breast cancer of Brazilian patients(Annually, during 5 years)
  • Main symptoms presented by patients with breast cancer in Brazil(Annually, during 5 years)
  • Type of palliative treatment for metastasis or recurrent breast cancer in Brazilian patients(Annually, during 5 years)
  • Types of clinical complications displayed by breast cancer Brazilian patients(Annually, during 5 years)
  • Description of the socioeconomical characteristics of the Brazilian population with breast cancer(Annually, during 5 years)
  • Classification of breast cancer staging(Annually, during 5 years)
  • Description of screening tests of breast cancer patients in Brazil(Annually, during 5 years)
  • Clinical outcome of Brazilian breast cancer patients(Annually, during 5 years)
  • Characterization of exterior factors that may impact clinical outcome of breast cancer Brazilian patients(Annually, during 5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验

Prospective Evaluation of Breast Cancer at Brazilian... | 临床试验